Skip to content
Neuromyelitis News logo
  • About NMOSD
    What is NMOSD?
    Causes
    Symptoms
    Diagnosis
  • Treatments
    Approved treatments
  • News
  • Columns
    The Beginner’s Guide to Walking — Jennifer V.
    Archived Columns
    • Courage to Care — Candice Galvan
    • Strength of the Soul — Mileidys Almaguer Iniguez
    • The View From Here — Lelainia Lloyd
  • What can we help you find today?

December 20, 2022 News by Lindsey Shapiro, PhD

2 Immune Cells Likely Culprits of NMOSD Attacks, Study Suggests

The activation of two types of immune cells — called natural killer (NK) and natural killer T-cells (NKT) — may contribute to the abnormal immune attacks that drive neuromyelitis optica spectrum disorder (NMOSD), a study suggested. The profile of these cells in NMOSD patients differed notably from that observed…

June 2, 2022 News by Marta Figueiredo, PhD

Uplizna Equally Effective in Patients With or Without Genetic Variants

Uplizna (inebilizumab-cdon) works to treat people with neuromyelitis optica spectrum disorder (NMOSD) regardless of whether such patients carry genetic variants linked to poor responses to other B-cell depleting therapies, new trial data show. An analysis of N-MOmentum Phase 2/3 data found that the approved therapy was as effective…

Recent Posts

  • Study IDs 4 proteins as potential drug targets for treating NMOSD
  • Telehealth is a useful supplement to in-person appointments
  • Rituximab, MMF may be effective off-label options for NMOSD: Study
  • Thank you, readers, for reminding me of the power of community
  • Infection rates lower with Enspryng over other immunosuppressives
  • Surviving the storms of life with lessons I’ve learned from NMOSD
  • Late-onset NMOSD linked to worse recovery, faster disability
  • Returning to acupuncture for pain management after 14 years
  • Enspryng helps patients remain relapse-free after 6 months: Study
  • For me, preventing relapses involves harsh medication side effects


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.